QURE

NASDAQ HEALTHCARE

Uniqure NV

$47.86

-$0.82 (-1.68%)

Live quote

52w: $8.73 – $71.50

Loading chart…

P/E Ratio—

P/B Ratio20.17

EV/EBITDA—

Debt/Equity—

ROE-133.23%

ROIC—

Revenue Growth-40.64%

Gross Margin—

uniQure NV, a gene therapy company, is dedicated to developing treatments for patients suffering from genetic and other devastating diseases. The company is headquartered in Amsterdam, the Netherlands.

Own QURE? Track it here.

Create a free account to add QURE to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account